A Case of Warfarin-induced Eosinophilia
Open Access
- 1 January 2012
- journal article
- case report
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 51 (12) , 1627-1629
Abstract
Warfarin is widely used in clinical practice all over the world. We report a man in whom prominent eosinophilia appeared after the initiation of warfarin administration following aortic valve replacement. Laboratory data following the administration and discontinuation of warfarin suggested that this drug was responsible for the eosinophilia. It is important to recognize the possibility of warfarin-induced hypereosinophilia as a latent adverse effect even when there are no clinical signs or symptoms.Keywords
This publication has 6 references indexed in Scilit:
- Apixaban versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2011
- Rivaroxaban versus Warfarin in Nonvalvular Atrial FibrillationNew England Journal of Medicine, 2011
- Dabigatran versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2009
- Incidence of peripheral blood eosinophilia and the threshold eosinophile count for indicating hypereosinophilia‐associated diseasesAllergy, 2002
- Eosinophilia Associated with CoumadinNew England Journal of Medicine, 1981
- Eosinophilia and Allergic Reactions to DrugsClinics in Haematology, 1980